Original Research

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A

Clinical Pharmacology: Advances and Applications 2018, 10:113-121

Published Date: 26 September 2018